We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+8.49%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.3B
AUM Growth
+$91M
Cap. Flow
-$6.54M
Cap. Flow %
-0.5%
Top 10 Hldgs %
34.31%
Holding
270
New
10
Increased
44
Reduced
91
Closed
6

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$1.24M
2
ON icon
ON Semiconductor
ON
+$940K
3
SYK icon
Stryker
SYK
+$884K
4
OGN icon
Organon & Co
OGN
+$748K
5
DE icon
Deere & Co
DE
+$623K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.69M
2
QCOM icon
Qualcomm
QCOM
+$1.55M
3
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$1.46M
4
VEEV icon
Veeva Systems
VEEV
+$1.36M
5
AAPL icon
Apple
AAPL
+$967K

Sector Composition

Rank Sector Weight
1 Technology 20.7%
2 Healthcare 18.34%
3 Financials 15.25%
4 Industrials 11.71%
5 Communication Services 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.B icon
26
Berkshire Hathaway Class B
BRK.B
$1.13T
$15.9M 1.22%
57,151
-135
-0.2% -$37.7K
PWR icon
27
Quanta Services
PWR
$101B
$15.9M 1.22%
175,303
-1,670
-0.9% -$157K
MCD icon
28
McDonald's
MCD
$195B
$14.9M 1.15%
64,416
+52
+0.1% +$12.1K
ABBV icon
29
AbbVie
ABBV
$435B
$14.3M 1.11%
127,372
-392
-0.3% -$44.1K
UNH icon
30
UnitedHealth
UNH
$370B
$13.9M 1.07%
34,801
-24
-0.1% -$9.57K
J icon
31
Jacobs Solutions
J
$17B
$13.9M 1.07%
126,127
-2,741
-2% -$310K
COST icon
32
Costco
COST
$420B
$13.9M 1.07%
35,038
+401
+1% +$152K
CRM icon
33
Salesforce
CRM
$158B
$12.2M 0.94%
50,081
-1,230
-2% -$283K
PG icon
34
Procter & Gamble
PG
$339B
$11.9M 0.91%
87,864
-1,968
-2% -$266K
ORCL icon
35
Oracle
ORCL
$423B
$11.3M 0.87%
144,646
-318
-0.2% -$24.9K
BMY icon
36
Bristol-Myers Squibb
BMY
$132B
$10.9M 0.84%
163,300
-194
-0.1% -$12.7K
EMR icon
37
Emerson Electric
EMR
$88.3B
$10.2M 0.78%
105,700
– –
BXMT icon
38
Blackstone Mortgage Trust
BXMT
$2.38B
$9.99M 0.77%
313,233
-2,420
-0.8% -$77.9K
INTC icon
39
Intel
INTC
$513B
$9.79M 0.75%
174,327
-700
-0.4% -$41.1K
PEP icon
40
PepsiCo
PEP
$190B
$9.44M 0.73%
63,729
+1,009
+2% +$147K
BP icon
41
BP
BP
$107B
$9.39M 0.72%
355,549
+2,995
+0.8% +$78.5K
ON icon
42
ON Semiconductor
ON
$31.6B
$9.13M 0.7%
238,400
+23,950
+11% +$940K
IBB icon
43
iShares Biotechnology ETF
IBB
$9.77B
$8.91M 0.69%
54,426
-208
-0.4% -$32K
VZ icon
44
Verizon
VZ
$196B
$8.59M 0.66%
153,239
+69
+0% +$3.96K
AXP icon
45
American Express
AXP
$230B
$8.14M 0.63%
49,277
-425
-0.9% -$66.6K
CVS icon
46
CVS Health
CVS
$122B
$8.13M 0.63%
97,484
-237
-0.2% -$19.4K
CVX icon
47
Chevron
CVX
$366B
$7.51M 0.58%
71,687
+225
+0.3% +$23.8K
RTX icon
48
RTX Corp
RTX
$301B
$7.46M 0.57%
87,498
-83
-0.1% -$6.99K
LIN icon
49
Linde
LIN
$226B
$7.04M 0.54%
24,347
+787
+3% +$229K
ADP icon
50
Automatic Data Processing
ADP
$108B
$6.77M 0.52%
34,069
-358
-1% -$69.6K
1
2
3 4 5

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q2 2021 Portfolio in Review

As of Q2 2021, Neville Rodie & Shaw held 270 positions worth $1.3B, up 7.5% from $1.21B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Neville Rodie & Shaw's Q2 2021 filing shows 10 new, 44 increased, 91 reduced and 6 closed positions. Its largest new stake was Stryker: 3,458 shares worth $898K. The largest sale was Merck, an estimated $1.69M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Neville Rodie & Shaw's largest Q2 2021 buy was Stryker: 3,458 shares worth $898K.
  • Neville Rodie & Shaw added most to Morgan Stanley in Q2 2021, an estimated $1.24M increase.
  • Neville Rodie & Shaw's biggest Q2 2021 reduction was Merck, cutting an estimated $1.69M.
  • Neville Rodie & Shaw fully exited Veeva Systems in Q2 2021, selling an estimated $1.36M.
  • Neville Rodie & Shaw's ten largest holdings make up 34% of its $1.3B portfolio in Q2 2021.
  • Neville Rodie & Shaw opened 10 new positions and closed 6 in Q2 2021.
  • Neville Rodie & Shaw's portfolio value rose 7.5% quarter-over-quarter to $1.3B.

Based on Neville Rodie & Shaw's 13F filing for Q2 2021, filed 6 Jul 2021.